Mark Aguillard

Mark Aguillard has a diverse work experience spanning multiple industries and roles. Mark is currently the Chief Commercial Officer at DermTech since 2023. Prior to that, they held the same position at Epic Sciences from 2021 to 2023, where they also served as the General Manager of the Oncology Business Unit from 2021 to 2023. Before joining Epic Sciences, Mark was the Chief Commercial Officer at binx health from 2020 to 2021.

Mark has also worked at Myriad Genetics, where they held various positions including General Manager of Women's Health from 2017 to 2020, National Sales Director of Oncology from 2016 to 2017, and Director of Managed Care from 2014 to 2015. Prior to Myriad Genetics, they were the Vice President of Marketing and Managed Care at OmniSeq from 2015 to 2016.

Earlier in their career, Mark worked at Myriad Genetics in multiple roles including Director of Managed Care from 2014 to 2015, Director of Marketing for the Oncology Business Unit from 2013 to 2014, Hereditary Cancer Product Manager from 2011 to 2013, Personalized Medicine Product Manager from 2010 to 2011, and Oncology Sales Manager from 2008 to 2010.

Before joining Myriad Genetics, Mark worked at Eli Lilly as a Neuroscience District Sales Manager from 2006 to 2008, an Area Sales Trainer from 2004 to 2006, and a Senior Sales Representative from 2001 to 2004. Mark started their career at Shell Oil Company as a Marketing Representative from 1997 to 2001.

Mark Aguillard attended Texas Tech University from 1993 to 1997, where they earned a Bachelor of Business Administration (BBA) degree with a focus on Finance.